BHC FY2025 SEC EDGAR DEF 14A #3 of 168 in industry

Bausch Health Companies Inc. CEO pay ratio

The CEO earned $16.9M in FY2025 against median worker pay of $42,062 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
NJ
Filing date
2026-04-08
Industry
Chemicals & Pharmaceuticals
Industry rank
#3/168

Data updated August 2026

Subscribe to Bausch Health Companies Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
401:1
Extreme (Scale: 0–1000:1)
CEO pay
$16.9M
Median worker
$42,062

Answer first

Bausch Health Companies Inc.'s FY2025 CEO total of $16.9M ranks #236 of 1,423 complete filings; its 401:1 pay ratio ranks #130. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $42,062. Industry placement uses the FY2025 SIC-28 peer cohort (# 3 of 168, 99th percentile - top 1% of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#236
$16.9M of 1,423 FY2025
Ratio rank
#130
401:1 of 1,423
Industry pct
99th
top 1% of industry peers by pay ratio

How Bausch Health Companies Inc. ranks nationally

Bausch Health Companies Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$16,877,326 Top 17% higher than 83% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). Below this entry. $12,500,000–$15,000,000: 91 companies (6%). Below this entry. $15,000,000–$17,500,000: 88 companies (6%). This entry sits in this band. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Bausch Health Companies Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($16.9M) against pay ratio (401:1) for Bausch Health Companies Inc. (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both5924457.816787382.627650307.538513232.449376157.322.3:1130.4:1238.5:1346.6:1454.6:1CEO total payPay ratio (CEO : median worker)Bausch Health Companies Inc., CEO total pay: 16877326 · Pay ratio (CEO : median worker): 401:1Bausch Health Companies Inc.Linde PLC, CEO total pay: 21777870 · Pay ratio (CEO : median worker): 428:1Linde PLCKeenova Therapeutics plc, CEO total pay: 47401080 · Pay ratio (CEO : median worker): 435:1Keenova Therapeutics plcPpg Industries Inc, CEO total pay: 16555264 · Pay ratio (CEO : median worker): 352:1Ppg Industries IncViatris Inc, CEO total pay: 15280383 · Pay ratio (CEO : median worker): 327:1Viatris IncELI LILLY & Co, CEO total pay: 36698337 · Pay ratio (CEO : median worker): 293:1ELI LILLY & Co
Bausch Health Companies Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Bausch Health Companies Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Bausch Health Companies Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
401:1
FY2025
vs prior FY
+31:1
from FY2024 370:1
CEO $ YoY
+3.9%
$16.9M latest
Filings shown
5
FY2021–2025
Bausch Health Companies Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $22.9M - $44,617 513:1 -
2022 $13.2M -42% $54,304 243:1 -270:1
2023 $15.9M +21% $44,328 358:1 +115:1
2024 $16.2M +2.3% $43,889 370:1 +12:1
2025 $16.9M +3.9% $42,062 401:1 +31:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 885590, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
401:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$16.9M
Companies in Industry
168
vs. Industry Median
Above
#3 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Bausch Health Companies Inc.: HIGH · PEAK pay ratio

Bausch Health Companies Inc.'s FY2025 ratio 401:1 ranks #3 of 168 Chemicals & Pharmaceuticals filers (99th percentile). the CEO earned 401× the median employee ($42,062) in FY2025.

Median employee $42,062 (PAR-MED); HIGH · PEAK stamps put about 401 median-wage years per CEO year.

CEO Total Pay

$16.9M

FY2025 Summary Compensation, well above median

Pay Ratio

401:1

Outlier, top decile

Bausch Health Companies Inc. in the higher Chemicals & Pharmaceuticals third

Bausch Health Companies Inc.'s FY2025 ratio 401:1 ranks #3 of 168 Chemicals & Pharmaceuticals filers (99th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Bausch Health Companies Inc.'s $16.9M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #236 and ratio rank #130 split - treat 401:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$16.9M
Median Employee Pay
$42,062
Pay Ratio
401:1
Filing Date
2026-04-08

Company Info

Ticker
BHC
CIK
885590
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
NJ
View SEC filings →
SEC EDGAR DEF 14A for CIK 885590, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Bausch Health Companies Inc.'s FY2025 ratio 401:1 ranks #3 of 168 Chemicals & Pharmaceuticals filers (99th percentile).

Read with Bausch Health Companies Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps HIGH · PEAK · PAR-MED.

Liberty Latin America Ltd. · PEAK

ABS(ceo_total_comp) peer at $16.9M (Δ $7K heavier vs Bausch Health Companies Inc.); HIGH · PAR-MED vs this page's HIGH · PEAK · PAR-MED.
Crown Castle Inc. · PEAK

ABS(ceo_total_comp) peer at $16.9M (Δ $13K lighter vs Bausch Health Companies Inc.); MID · ELITE-MED vs this page's HIGH · PEAK · PAR-MED.
SentinelOne, Inc. · PEAK

ABS(ceo_total_comp) peer at $16.9M (Δ $49K heavier vs Bausch Health Companies Inc.); MID · ELITE-MED vs this page's HIGH · PEAK · PAR-MED.
Xeris Biopharma Holdings, Inc. · PEAK

ABS(ceo_total_comp) peer at $16.9M (Δ $60K heavier vs Bausch Health Companies Inc.); MODEST · ELITE-MED vs this page's HIGH · PEAK · PAR-MED.
Linde PLC (SIC 28 pole)

Linde PLC stamps HIGH · PEAK nearest in-SIC by ABS(pay_ratio) to Bausch Health Companies Inc.'s HIGH filing.
National dual ranks · #236/#130

Bausch Health Companies Inc.'s FY2025 package sits #236 by CEO dollars and #130 by ratio under PEAK · HIGH.
Comp structure · PEAK

Bausch Health Companies Inc.'s PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for Bausch Health Companies Inc. (CIK 885590), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.